BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6367013)

  • 1. Arhus County Vagotomy Trial: ulcer recurrence rate related to alterations in gastric acid secretion after selective gastric and parietal cell vagotomy.
    Ornsholt J; Amdrup E; Andersen D; Høstrup H
    Scand J Gastroenterol; 1983 May; 18(4):465-72. PubMed ID: 6367013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arhus County Vagotomy Trial: gastric secretory alterations during the first year after selective gastric and parietal cell vagotomy.
    Ornsholt J; Amdrup E; Andersen D; Høstrup H
    Scand J Gastroenterol; 1983 May; 18(4):455-63. PubMed ID: 6367012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric acid response to sham feeding and pentagastrin before and after parietal cell vagotomy in patients with duodenal ulcer.
    Nielsen HO; Bekker C; Kronborg O; Andersen D
    Scand J Gastroenterol; 1982 Jan; 17(1):133-6. PubMed ID: 7134828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective controlled vagotomy trial for duodenal ulcer: primary results, sequelae, acid secretion, and recurrence rates two to five years after operation.
    Christiansen J; Jensen HE; Ejby-Poulsen P; Bardram L; Henriksen FW
    Ann Surg; 1981 Jan; 193(1):49-55. PubMed ID: 7006528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid secretory tests in peptic ulcer disease before and after parietal cell vagotomy.
    Graffner H; Liedberg G; Oscarson J
    Scand J Gastroenterol; 1986 Jan; 21(1):41-6. PubMed ID: 3513293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid secretion and its predictive value after vagotomy for perforated duodenal ulcer.
    Koo J; Lam SK; Boey J; Lee NW
    Scand J Gastroenterol; 1983 Oct; 18(7):929-34. PubMed ID: 6374869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should it be parietal cell vagotomy or selective vagotomy-antrectomy for treatment of duodenal ulcer? A progress report.
    Jordan PH; Thornby J
    Ann Surg; 1987 May; 205(5):572-90. PubMed ID: 3555364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent ulceration after highly selective vagotomy for duodenal ulcer.
    Blackett RL; Johnston D
    Br J Surg; 1981 Oct; 68(10):705-10. PubMed ID: 7025957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vagotomy.
    Cohen F; Valleur P; Serra J; Brisset D; Chiche L; Hautefeuille P
    Ann Surg; 1993 Mar; 217(3):253-9. PubMed ID: 8452404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical treatment of duodenal ulcer.
    Amdrup E
    Schweiz Med Wochenschr; 1979 Apr; 109(16):583-5. PubMed ID: 432586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized study comparing highly selective vagotomy and extended highly selective vagotomy in patients with duodenal ulcer.
    Braghetto I; Csendes A; Lazo M; Rebolledo P; Díaz A; Bardavid A; Bahamonde A; Thomet G
    Am J Surg; 1988 Mar; 155(3):443-6. PubMed ID: 3344909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid and pepsin responses to graded doses of pentagastrin in duodenal and corporeal gastric ulcer patients before and after selective proximal vagotomy.
    Emås S; Aly A
    Am J Surg; 1985 Nov; 150(5):543-9. PubMed ID: 3933370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endogenous pancreatic glucagon on gastric acid secretion in patients with duodenal ulcer before and after parietal cell vagotomy.
    Loud FB; Chirstiansen J; Holst JJ; Petersen B; Kirkegaard P
    Gut; 1981 May; 22(5):359-62. PubMed ID: 7250747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parietal cell vagotomy and truncal vagotomy as treatment of duodenal ulcer. A prospective randomized trial.
    Selking O; Krause U; Nilsson F; Thorén L
    Acta Chir Scand; 1981; 147(7):561-7. PubMed ID: 7048827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy.
    Olsen PS; Pedersen JH; Kirkegaard P; Been H; Stadil F; Fahrenkrug J; Christiansen J
    Gut; 1984 May; 25(5):481-4. PubMed ID: 6714791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parietal cell vagotomy in the surgical treatment of chronic duodenal, pyloric and prepyloric ulcer disease.
    Graffner HO; Liedberg GF; Oscarson JE
    Int Surg; 1985; 70(2):139-44. PubMed ID: 4055278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One hundred patients ten years after parietal cell vagotomy.
    Staël von Holstein C; Graffner H; Oscarson J
    Br J Surg; 1987 Feb; 74(2):101-3. PubMed ID: 3545366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proximal gastric vagotomy on serum pepsinogen I and II concentrations and acid secretion in duodenal ulcer patients.
    Feldman M; Blair AJ; Richardson CT; Samloff IM
    Dig Dis Sci; 1988 Jul; 33(7):824-7. PubMed ID: 3378476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum group I pepsinogens in unoperated duodenal ulcer patients and in duodenal ulcer patients after proximal gastric vagotomy.
    Lalla M; Paimela H; Räsänen V
    Scand J Gastroenterol; 1983 May; 18(3):397-9. PubMed ID: 6369516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy.
    Feldman M; Richardson CT
    Gastroenterology; 1986 Mar; 90(3):540-4. PubMed ID: 3943686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.